Morgan Stanley’s BNY Mellon Concentrated Growth ETF BKCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
11,617
-467
-4% -$17.3K ﹤0.01% 5613
2026
Q1
$411K Sell
12,084
-278
-2% -$10K ﹤0.01% 5576
2025
Q4
$450K Sell
12,362
-243
-2% -$8.74K ﹤0.01% 5563
2025
Q3
$450K Buy
12,605
+2,800
+29% +$97.5K ﹤0.01% 5543
2025
Q2
$339K Buy
9,805
+164
+2% +$5.21K ﹤0.01% 5637
2025
Q1
$298K Buy
+9,641
New +$298K ﹤0.01% 5566

Other funds holding BKCG

Morgan Stanley's BKCG Position: Q2 2026 in Review

Morgan Stanley reduced its BNY Mellon Concentrated Growth ETF (BKCG) stake by 3.9% in Q2 2026, selling an estimated $17.3K and leaving 11,617 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #5613.

Morgan Stanley first reported a position in BKCG in Q1 2025 and has held it in 6 quarters since. The position peaked at $450K in Q4 2025. 26 funds tracked by Wall St. Rank hold BKCG as of Q2 2026.

  • Morgan Stanley held 11,617 shares of BNY Mellon Concentrated Growth ETF worth $433K as of Q2 2026.
  • Morgan Stanley sold 467 BNY Mellon Concentrated Growth ETF shares in Q2 2026, an estimated $17.3K.
  • BNY Mellon Concentrated Growth ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5613 holding.
  • Morgan Stanley first reported a position in BNY Mellon Concentrated Growth ETF in Q1 2025 and has held it in 6 quarters since.
  • Morgan Stanley's BNY Mellon Concentrated Growth ETF position peaked at $450K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held BNY Mellon Concentrated Growth ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.